How to Choose Recombinant Proteins for Antibody Affinity Measurement
To choose a recombinant protein for antibody-affinity measurement, select an antigen containing the antibody’s recognized epitope that is also compatible with the intended SPR or BLI immobilization strategy. Confirm the species, sequence boundaries, expression system, tag orientation, purity, concentration, aggregation status, and formulation before ordering. Avi-tagged, biotinylated, His-tagged and tag-free proteins support different sensor configurations, while selected nanodisc or validated VLP proteins may be required for conformational membrane targets.
Beta LifeScience supplies catalog, semi-custom and fully custom recombinant proteins for antibody screening, binding studies and affinity measurements. Researchers can compare available targets or submit their assay platform, capture method and protein requirements for a project-specific quotation.
Need an SPR- or BLI-Compatible Recombinant Protein? Send your target, species, antibody format, assay platform, and immobilization requirements for product-selection support and current pricing.
Request an Affinity-Assay Protein Quote

Recombinant Proteins for SPR and BLI
Antibody-affinity measurements require more than a protein with the correct target name. The recombinant antigen must present the relevant epitope while remaining compatible with the selected sensor, immobilization method, and running buffer.
|
Research requirement |
Protein solution |
|
Standard soluble antigen |
Catalog recombinant protein |
|
Controlled streptavidin-surface loading |
Avi-tagged or biotinylated protein |
|
Ni-NTA sensor loading |
His-tagged recombinant protein |
|
Reduced tag-related interference |
Tag-free protein |
|
Fc-related interaction study |
Fc-tagged protein or Fc receptor selected for the assay design |
|
Multi-pass membrane target |
Nanodisc or validated VLP protein |
|
Modified catalog protein |
Semi-custom protein production |
|
New sequence, mutation or construct |
Full custom protein expression |
|
Larger screening campaign |
Project-specific quantity and scale-up evaluation |
Review the individual product page before purchasing. Product-specific sequence, tag, purity, formulation, activity data, and SPR or BLI compatibility can vary.
Quick Protein Selection Checklist
Before requesting a quotation, confirm:
- Exact target and species
- UniProt accession number
- Required isoform or mutation
- Full-length Protein, extracellular domain, or specific fragment
- Antibody epitope, if known
- SPR, BLI or another affinity platform
- Which binding partner will be immobilized
- Required immobilization chemistry
- Preferred tag and tag position
- Required protein concentration and quantity
- Purity and aggregation requirements
- Buffer restrictions
- Whether biotinylation is required
- Required QC and activity documentation
Providing these details early allows the supplier to recommend an existing catalog product or evaluate a suitable custom construct.
Match the Protein Sequence to the Antibody Epitope
The selected recombinant Protein must contain the epitope recognized by the antibody. A protein can carry the correct target name but remain unsuitable if its sequence omits the relevant binding region.
Check:
- Protein sequence boundaries
- Extracellular versus intracellular regions
- Mature Protein versus precursor sequence
- Isoform-specific regions
- Signal-peptide removal
- Post-translational modifications
- Mutations or polymorphisms
- Tag location relative to the epitope
For an antibody recognizing a linear epitope, a purified fragment may be sufficient. An antibody recognizing a conformational epitope may require a correctly folded domain, the complete extracellular region, or a membrane-associated protein format.
If the epitope is unknown, a longer construct may provide broader coverage. Longer proteins can, however, introduce additional folding, stability, and immobilization considerations. Final selection should balance epitope coverage with assay compatibility.

Choose Full-Length Protein, Domain or Fragment
The largest available construct is not automatically the best recombinant antigen for antibody-affinity measurement.
|
Protein format |
Potential advantage |
Selection consideration |
|
Full-length soluble protein |
Broad epitope coverage |
May be more difficult to express or stabilize |
|
Extracellular domain |
Relevant for many receptor-targeting antibodies |
Confirm boundaries and folding |
|
Functional domain |
More defined interaction surface |
Must include the recognized epitope |
|
Short fragment |
Simpler production and reduced molecular complexity |
May not reproduce conformational epitopes |
|
Nanodisc protein |
Membrane-associated presentation |
Requires a compatible capture strategy |
|
VLP-displayed protein |
Full-length membrane target presentation |
Confirm product-specific SPR or BLI validation |
|
Fc-fusion protein |
May improve stability or dimerization |
Fc can influence orientation and avidity |
The selected construct should reproduce the antigenic state relevant to the research question. For example, an antibody developed against a native receptor may bind differently to a short bacterially expressed fragment.
Select an Appropriate Expression System
The expression host can affect protein folding, disulfide-bond formation, glycosylation and biological activity.
Mammalian expression
Mammalian cells are frequently selected for extracellular receptors, cytokines and other targets requiring complex folding or mammalian-like post-translational modifications. This can be important when antibody binding depends on protein conformation or glycosylation.
Insect-cell expression
Insect cells can support the production of folded eukaryotic proteins and may provide an alternative for targets that are difficult to produce in mammalian cells. Their glycosylation patterns differ from those produced in mammalian systems.
E. coli expression
Bacterial expression can be efficient for non-glycosylated proteins, individual domains, and protein fragments. It may be appropriate when an antibody recognizes a sequence-based epitope that does not depend on mammalian post-translational modifications.
Yeast expression
Yeast offers a scalable eukaryotic production route. Protein-specific glycosylation and processing should still be considered when selecting a yeast-expressed target for antibody-binding studies. Choose the expression system according to the epitope and protein requirements rather than assuming one host is suitable for every affinity assay.
Choose the Right Immobilization Strategy
SPR and BLI measurements depend strongly on how one binding partner is presented on the sensor surface. Random or excessive immobilization may mask the epitope, restrict molecular movement, or create heterogeneous binding.
|
Immobilization strategy |
Protein format |
Buying consideration |
|
Streptavidin capture |
Biotinylated or enzymatically biotinylated Avi-tagged protein |
Confirm actual biotinylation status |
|
Ni-NTA capture |
His-tagged protein |
Confirm tag accessibility and position |
|
Direct amine coupling |
Protein with accessible primary amines |
Formulation must support coupling |
|
Fc capture |
Fc-fusion protein |
Consider dimerization and avidity |
|
Antibody capture |
Untagged antigen used as the analyte |
Requires accurate antigen concentration |
|
Membrane-protein capture |
Validated nanodisc or VLP protein |
Confirm compatible tag and capture chemistry |
Select the planned sensor chemistry before purchasing the Protein. This reduces the risk of ordering a format that cannot be immobilized in the required orientation.

Avi-Tagged and Biotinylated Proteins
Avi-tagged proteins are frequently selected when controlled immobilization on a streptavidin-coated sensor is required. The Avi tag contains a defined sequence that can be enzymatically biotinylated.
An Avi tag does not automatically mean the supplied Protein has already been biotinylated. Check the product specifications for:
- Confirmed biotinylation
- Biotinylation method
- Tag position
- Degree of labeling, when available
- Recommended sensor type
- Protein concentration and formulation
Site-specific biotinylation can support more consistent surface orientation than random chemical labeling. Suitability still depends on tag accessibility and the location of the antibody epitope.
Researchers can compare Avi-tagged proteins and biotinylated recombinant proteins for potentially compatible catalog options.
His-Tagged and Tag-Free Proteins
His-tagged proteins can be captured using Ni-NTA biosensors or compatible SPR surfaces. This format is widely available and may simplify affinity-assay development.
Before selecting a His-tagged antigen, verify:
- N-terminal or C-terminal tag position
- Whether the tag is exposed
- Whether the antibody recognizes a nearby epitope
- Whether the formulation contains interfering components
- Whether tag-mediated loading is sufficiently stable
A tag-free protein may be preferred when the tag could affect the interaction or recognized epitope. Tag-free proteins may be used as analytes or immobilized through another coupling method.
When comparing protein tags, consider the complete assay architecture—not only the convenience of surface capture.
Review Purity, Aggregation and Concentration
Affinity measurements depend on the concentration of binding-competent Protein rather than total Protein alone. Aggregates, fragments, or inactive material can affect the apparent binding response.
Protein purity
Review the stated purity and analytical method, such as SDS-PAGE or HPLC. A purity percentage does not independently confirm monodispersity, correct folding, or biological activity, so assess all available QC information.
Aggregation
Aggregated antigen can create multivalent interactions and may produce an artificially slow dissociation response. Size-exclusion chromatography or another appropriate analytical method can help evaluate aggregation when available or requested.
Concentration
Accurate molar concentration is needed for kinetic measurements. Confirm:
- Protein concentration
- Molecular weight
- Oligomeric state
- Concentration-measurement method
- Whether the reported molecular mass includes fusion tags
- Whether the complete supplied quantity is recoverable after reconstitution
If active protein concentration or advanced characterization is essential, include the requirement in the quotation request.

Check the Protein Formulation
A high-quality protein may still be incompatible with an affinity platform if its formulation conflicts with the planned immobilization or detection method.
Review the buffer for:
- pH
- Salt concentration
- Glycerol
- Detergents
- Reducing agents
- Carrier proteins
- Preservatives
- Trehalose and other stabilizers
- Free biotin
- Imidazole
- Sodium azide
Carrier proteins such as BSA can affect direct immobilization or concentration measurement. Free biotin may compete with a biotinylated antigen for streptavidin binding. High concentrations of glycerol, detergent, or salt can influence the baseline or refractive-index response. Select a formulation that can be used directly or safely buffer-exchanged without destabilizing the recombinant Protein.
Soluble and Membrane Proteins Require Different Formats
Soluble extracellular domains are suitable for many antibody-affinity studies. However, antibodies recognizing conformational or discontinuous epitopes may require a target presented in a membrane-associated environment. Multi-pass membrane targets—including GPCRs, transporters and ion channels—may require VLP, nanodisc or another stabilized membrane-protein format.
The recombinant transmembrane protein collection includes VLP, nanodisc and detergent-solubilized formats. Each format supports different research requirements:
- Nanodisc proteins can support selected SPR and BLI kinetic studies when the protein format and immobilization method are compatible.
- VLP-displayed proteins can support antibody screening, ELISA, and selected SPR or BLI workflows when product-specific assay validation and compatible capture chemistry are available. Confirm the recommended application and supporting data on the individual product page before ordering.
- Detergent-solubilized proteins may support biochemical, binding, and structural workflows, but detergent and sensor compatibility must be evaluated for the intended platform.
The current transmembrane-protein collection includes Biotinylated Human CLDN6 VLP case-study data from both SPR and BLI assays using compatible streptavidin-based capture methods. This illustrates why affinity-assay suitability should be determined from product-specific validation rather than the protein format alone.

Why Source Affinity-Assay Proteins from Beta LifeScience?
Beta LifeScience supports antibody-affinity studies with catalog, semi-custom, and full-custom recombinant protein options. Researchers can select soluble, Avi-tagged, biotinylated, His-tagged, tag-free and membrane-protein formats according to their SPR or BLI assay design.
Project-specific support may include:
- Recombinant proteins across multiple species and target families
- Mammalian, insect, bacterial and yeast expression options
- Tag, sequence, mutation and construct customization
- Biotinylated and Avi-tagged protein formats
- Nanodisc and selected VLP formats for conformational targets
- Custom formulation, concentration, quantity and QC evaluation
- Technical product-selection and quotation support
Availability, specifications, testing options, pricing and lead time should be confirmed for the selected catalog product or custom project.
|
Buyer requirement |
Available option |
|
Ready-to-order soluble target |
Catalog recombinant protein |
|
Controlled sensor immobilization |
Avi-tagged or biotinylated protein |
|
Ni-NTA sensor capture |
His-tagged protein |
|
Reduced tag-related interference |
Tag-free protein |
|
Conformational membrane target |
Nanodisc or validated VLP format |
|
Modified catalog protein |
Semi-custom production |
|
New sequence or construct |
Full custom protein expression |
|
Different quantity or formulation |
Project-specific evaluation |
Request Product Selection Support
Featured Recombinant Proteins for Antibody-Affinity Measurement
The following catalog examples illustrate different protein formats for antibody-binding and affinity workflows. Final selection should be based on the complete product specifications, assay platform, and intended immobilization method.
|
Product |
Protein format |
Best-fit application |
Action |
|
Full-length mammalian-expressed nanodisc, C-His |
SPR measurement of antibody binding to a conformational GPCR target |
||
|
Nanodisc membrane protein |
GPRC5D antibody screening and binding studies |
||
|
Biotinylated HEK293-expressed nanodisc |
Streptavidin-based capture of a conformational GPCR target |
||
|
Biotinylated nanodisc transporter |
Antibody binding studies requiring membrane-associated presentation |
||
|
HEK293-expressed His-Avi-tagged protein |
Biotin-based immune-checkpoint binding assays |
||
|
Active soluble cytokine |
Soluble antibody–cytokine interaction studies |
These products are provided as initial selection examples. Confirm the complete sequence, tag, purity, concentration, formulation, biotinylation status, and SPR or BLI compatibility on the individual product page before ordering.
Need Help Selecting an Affinity-Assay Protein? Provide your antibody format, target, instrument and immobilization plan for technical product-selection support.
Request Product Selection Support
Catalog, Semi-Custom or Full Custom Production?
A catalog protein is generally the most direct route when its sequence, host, tag, and formulation already match the assay.
Consider semi-custom protein production when an existing catalog target requires a modified:
- Tag or tag position
- Formulation
- Sequence range
- Endotoxin specification
- Quantity
- Liquid or lyophilized format
Use full custom protein expression when the project requires:
- A new sequence or construct
- Specific mutations
- A different expression host
- Defined domain boundaries
- Custom biotinylation or tag design
- A protein unavailable in the catalog
- Project-specific purification and QC
Project feasibility, pricing, milestones, deliverables, and lead time depend on the Protein and requested specifications.
Information to Include with Your Inquiry
A well-qualified inquiry should include:
- Target name, species, and UniProt accession
- Required sequence or construct boundaries
- Known antibody epitope
- Antibody isotype and format
- SPR or BLI instrument
- Planned sensor chemistry
- Immobilized binding partner
- Required protein tag and orientation
- Preferred expression system
- Quantity and concentration
- Purity and aggregation requirements
- Buffer restrictions
- Required QC or activity testing
- Expected project schedule
These details help determine whether a catalog protein is suitable or whether a semi-custom or fully custom route is required.
FAQs
What recombinant Protein is best for SPR antibody-affinity measurement?
The best Protein contains the recognized epitope, remains stable in the running buffer, and supports the planned immobilization method. Avi-tagged, biotinylated, His-tagged, and tag-free proteins can each be appropriate depending on the assay design.
Are Avi-tagged proteins already biotinylated?
Not always. An Avi tag provides an enzymatic biotinylation site, but the product specifications must confirm that biotinylation has been completed before the Protein is used with a streptavidin sensor.
Can His-tagged proteins be used for BLI?
His-tagged proteins can be captured using compatible Ni-NTA biosensors. Confirm that the tag is accessible and positioned away from the antibody epitope.
What protein purity is required for affinity measurement?
The appropriate purity depends on the assay, but purity alone is not sufficient. Protein concentration, aggregation, folding, biological activity, and formulation should also be reviewed.
Can membrane proteins be used for SPR or BLI?
Yes. Selected nanodisc and VLP-displayed proteins can support SPR or BLI when product-specific validation and compatible capture chemistry are available. Confirm the recommended applications and supporting data on the individual product page.
Could you please provide a different tag, sequence, or formulation?
Yes. Semi-custom or full custom production can be evaluated for a different tag, sequence range, mutation, expression system, formulation, concentration, or quantity.
Find the Right Protein for Your Antibody-Affinity Assay
Choose a recombinant protein that reproduces the relevant antibody epitope and fits the complete affinity-assay design. Sequence boundaries, folding, expression host, tag orientation, immobilization chemistry, purity, aggregation and formulation can all affect the resulting binding data.
Send your target sequence, antibody format, required quantity, purity, and planned SPR or BLI setup to receive a project-specific product recommendation and quotation.